Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0000950170-24-105616

Director sold 11,016 shares at $91.31 ($1,005,871)

  • Director acquired 11,016 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Saad Mark E Director 2024-09-11 Option exercise 10b5-1 +11,016 $3.67 $40,429 21,018 D
Saad Mark E Director 2024-09-11 Sale 10b5-1 −11,016 $91.31 $1,005,871 10,002 D
Derivatives
Saad Mark E Director 2024-09-11 Option exercise · Stock Option (Right to Buy) 10b5-1 −11,016 0 D
Open-market sales · 11,016 sh · avg $91.31 · $1,005,871
Loading xslF345X05/ownership.xml…